NORTHERN TRUST CORP - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 178 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$11,943,518
+4.8%
582,895
+1.6%
0.00%0.0%
Q2 2023$11,401,367
+21.7%
573,798
+4.9%
0.00%0.0%
Q1 2023$9,371,926
-11.5%
547,106
+1.1%
0.00%0.0%
Q4 2022$10,593,300
+54.8%
541,303
+26.3%
0.00%0.0%
Q3 2022$6,842,000
+15.3%
428,685
-0.6%
0.00%
+100.0%
Q2 2022$5,933,000
-8.9%
431,247
+5.1%
0.00%0.0%
Q1 2022$6,510,000
-27.6%
410,456
-0.4%
0.00%0.0%
Q4 2021$8,996,000
-27.4%
412,080
-0.6%
0.00%
-50.0%
Q3 2021$12,394,000
-34.7%
414,618
-3.3%
0.00%
-33.3%
Q2 2021$18,983,000
+0.7%
428,604
+0.9%
0.00%
-25.0%
Q1 2021$18,842,000
-16.2%
424,650
+3.6%
0.00%0.0%
Q4 2020$22,474,000
+138.6%
409,807
-0.5%
0.00%
+100.0%
Q3 2020$9,419,000
+3.7%
411,995
-5.1%
0.00%0.0%
Q2 2020$9,087,000
+58.4%
434,146
+5.6%
0.00%0.0%
Q1 2020$5,735,000
-29.6%
411,081
+14.8%
0.00%0.0%
Q4 2019$8,146,000
+89.1%
357,940
-3.2%
0.00%
+100.0%
Q3 2019$4,307,000
-6.9%
369,736
+19.9%
0.00%0.0%
Q2 2019$4,624,000
-13.7%
308,274
+0.9%
0.00%0.0%
Q1 2019$5,359,000
+25.9%
305,490
+6.3%
0.00%0.0%
Q4 2018$4,258,000
-36.6%
287,320
+5.3%
0.00%
-50.0%
Q3 2018$6,718,000
+43.1%
272,850
+14.1%
0.00%
+100.0%
Q2 2018$4,693,000
+656.9%
239,036
+622.2%
0.00%
Q1 2018$620,00033,0980.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 16,037,486$280,250,00019.13%
TANG CAPITAL MANAGEMENT LLC 2,965,485$52,015,0009.58%
Boxer Capital, LLC 1,466,051$25,715,0002.97%
Ghost Tree Capital, LLC 600,000$10,524,0002.75%
BRIDGER MANAGEMENT, LLC 1,529,032$26,819,0002.12%
Cormorant Asset Management, LP 1,700,000$29,818,0002.02%
EcoR1 Capital, LLC 450,000$7,893,0000.73%
UNIVERSITY OF NOTRE DAME DU LAC 171,015$3,000,0000.67%
Virtus ETF Advisers LLC 17,799$312,0000.66%
SPHERA FUNDS MANAGEMENT LTD. 290,001$5,087,0000.46%
View complete list of ROCKET PHARMACEUTICALS INC shareholders